YPO Welcomes 2018 YPO Innovation Week Sponsors
DALLAS, April 24, 2018 (GLOBE NEWSWIRE) -- YPO, the world's premier leadership organization of chief executives, announced today that Techstars has joined as a gold sponsor and Geniecast, Emplify and Telluride are silver sponsors of the 2018 YPO Innovation Week.
YPO Innovation Week sponsors offer valuable insight, key connections and respected expertise that made the world's largest and most impactful innovation initiative possible.
"YPO Innovation Week brings together some of the most innovative and disruptive leaders around the world," said YPO CEO Scott Mordell. "We are so pleased to partner with these prestigious and forward-thinking organizations and businesses to help elevate the week's experiences for our members and take innovation to the next level."
During the week of 7-11 May 2018, YPO will host innovation events across the globe from Sydney, Australia to London, England; Tel Aviv, Israel to New York, New York, USA; Santo Domingo, Dominican Republic to Palo Alto, California, USA and Nairobi, Kenya, and more.
The mission of YPO Innovation Week is to drive innovation and transformation across a diverse range of industries and sectors through signature events, live interactive video casts and livestream events across more than 30 countries. Business leaders and pioneering thinkers will engage in a weeklong forum discussing the most important innovations affecting business today, including augmented and virtual reality, vehicle technology, digital imaging, wearables, smart home, sensors and more.
"We welcome these prestigious partners and their participation in the 2018 YPO Innovation Week," said YPO Innovation Week Chair Keith Alper. "With their support, we will truly be able to overturn conventional thinking and inspire business leaders to accelerate what's next."
Techstars is featuring Techstars Founders who will deliver pitches at several YPO Innovation Week events, including the Global FinTech Summit, the World Technology Summit and the NYSE Closing Bell event.
Geniecast is hosting digital events throughout YPO Innovation Week via two-way video broadcast.
Emplify's CEO Santiago Jaramillo, a YPO member, will present on the future of work at the Silicon Valley Summit and World Technology Summit.
Telluride is hosting a virtual reality space at the Silicon Valley Summit and providing an exclusive prize package for YPO Global Innovation Award finalists.
The premier leadership organization of chief executives in the world.
YPO is the global platform for chief executives to engage, learn and grow. YPO members harness the knowledge, influence and trust of the world's most influential and innovative business leaders to inspire business, personal, family and community impact.
Today, YPO empowers more than 25,000 members in more than 130 countries, diversified among industries and types of businesses. Altogether, YPO member-run companies employ more than 16 million people and generate USD6 trillion in annual revenues.
Leadership. Learning. Lifelong. For more information, visit YPO.org.
Techstars is the worldwide network that helps entrepreneurs succeed. Techstars founders connect with other entrepreneurs, experts, mentors, alumni, investors, community leaders, and corporations to grow their companies. Techstars operates four divisions: Techstars Startup Programs, Techstars Mentorship-Driven Accelerator Programs, Techstars Corporate Innovation Partnerships, and the Techstars Venture Capital Fund. Techstars portfolio includes more than 1,300 companies with a market cap of $12 billion. www.techstars.com
Geniecast is transforming the way the world connects people, ideas, and inspiration. We are curators, producers, and distributors of the world's largest online marketplace of thought leaders, athletes, speakers, celebrities, facilitators and more - all available via two-way, live video broadcast. Join us in the quest to inspire, lead, and evolve. At Geniecast, we strive to offer human-centric client services through great people and clever technology, one transaction at a time. From a warm welcome to individualized attention, we engage with you, one connection at a time. And, when you least expect it, we plan to surprise you with an extra touch, one experience at a time. To learn more, visit https://geniecast.com/.
Emplify, the industry leader in data-driven employee analytics and action-enabling insights for business leaders, helps executives leverage employee insights to make their workforce more successful. Backed by decades of research in human psychology and neuroscience, Emplify InsightsTM blends employee engagement best practices and hands-on expert coaching into an agile feedback system that's simple yet more effective than historic annual employee surveys, and more trustworthy than modern pulse surveys. Emplify is trusted by companies like Ivy Tech Community College, Herff Jones, Harley Davidson, Cheetah Digital, Crew Carwash, Yamaha, and many others. Learn more at emplify.com.
Forty-five minutes from the nearest stoplight, at the end of a incredibly beautiful box canyon sits Telluride, Colorado, a National Historic Landmark surrounded by the highest concentration of 13,000' and 14,000' peaks in the United States. Above Telluride is a modern mountain village connected by a gondola, the only one of its kind in North America. While the ski terrain is world-renowned, the resort is truly defined by a collection of intimate and unmatched experiences. With your first walk down the historic main street, you'll find the character and charm of Telluride as special as the majestic San Juan Mountains. To learn more, visit www.tellurideskiresort.com .
Office: +1 972 629 7305 (United States)
Mobile: +1 972 207 4298
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: YPO via Globenewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Følg saker fra GlobeNewswire
Registrer deg med din epostadresse under for å få de nyeste sakene fra GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra GlobeNewswire
Abeona Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results18.3.2019 21:45:00 CET | Pressemelding
On track to initiate Phase 3 VITAL™ trial for treatment of RDEB in mid-2019; EB-101 to be manufactured in-house Manufacturing scaled to support AAV based programs; GMP readiness expected 2H19 Investor conference call on Tuesday, March 19 at 10:00 a.m. ET NEW YORK and CLEVELAND, March 18, 2019 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a leading clinical-stage biopharmaceutical company developing novel cell and gene therapies for serious diseases, today announced fourth quarter and full year 2018 financial results, and provided business highlights. The Company will host a conference call on Tuesday, March 19 at 10:00 a.m. ET to discuss fourth quarter and full year results, and to provide business highlights. Interested parties are invited to participate in the call by dialing 844-369-8770 (toll-free domestic) or 862-298-0840 (International) or via webcast at https://www.investornetwork.com/event/presentation/44847. “The diligent work conducted over the past nine months
Novavax Reports Fourth Quarter and Year-End 2018 Financial Results18.3.2019 21:05:00 CET | Pressemelding
Company to Host Conference Call Today at 4:30 p.m. ET GAITHERSBURG, Md., March 18, 2019 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX) today announced its financial results and operational highlights for the fourth quarter and twelve months ended December 31, 2018. “In 2018, we committed to focus on our two lead programs, ResVax™ and Nanoflu™, and reflecting on last year’s activities, I am proud to say we have achieved significant results for both,” said Stanley C. Erck, President and CEO of Novavax, Inc. “Although we were disappointed to miss the primary endpoint of our Prepare trial, ResVax is the first RSV vaccine to demonstrate efficacy for the prevention of RSV disease in a Phase 3 clinical trial. In addition, the successful Phase 2 results for our NanoFlu vaccine provide an opportunity to now confirm with the FDA the use of accelerated approval for licensure. We are now prepared to make meaningful advances on these programs during 2019.” Fourth Quarter 2018 and Subsequent Opera
Mattson Technology Announces Hydrilis™, a Unique High-Productivity Vacuum Wafer Process Platform18.3.2019 17:00:00 CET | Pressemelding
– Up to 4 process chambers and 8 wafer processing stations – – Smallest footprint, highest throughput platform – – Enables any process chamber, any position configuration flexibility – FREMONT, Calif., March 18, 2019 (GLOBE NEWSWIRE) -- Mattson Technology, Inc., a leading supplier of advanced process equipment used to manufacture semiconductors, introduces Hydrilis™, the industry’s highest productivity density vacuum transfer platform featuring high throughput on the smallest footprint. The Hydrilis platform can be configured with up to 4 process chambers, or 8 processing stations, for parallel or sequential wafer processing. Any of the paradigmE® family plasma etch process chambers, Suprema® family plasma photoresist strip and hard-mask removal process chambers, Novyka™ family surface treatment process chambers and Novyka family selective chemical dry etch process chambers can all be integrated on the Hydrilis platform. “Throughput per unit area of fab space is one of the key criteria
Minerva Neurosciences to Host Webcast Event on Schizophrenia18.3.2019 13:30:00 CET | Pressemelding
Decision Resources Group to provide review of the disease landscape and forecast Key opinion leader to discuss negative symptoms in schizophrenia Minerva to outline roluperidone’s potential position within the disease landscape WALTHAM, Mass., March 18, 2019 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) disorders, today announced that it will host a webcast, “Schizophrenia: Disease Landscape and Forecast,” on Thursday, March 21, 2019 beginning at 10:00 a.m. eastern time in Boston, MA. Minerva’s Executive Chairman and Chief Executive Officer, Remy Luthringer, Ph.D., will be joined by representatives from Decision Resources Group, a global information and technology services company providing proprietary data and solutions to the healthcare industry, and Dr. Gregory Strauss, an expert key opinion leader. Discussions will feature the following speakers
Infovista Enhances Ipanema SD-WAN with Nextgen Application Intelligence+ and Cloud-Native Orchestration18.3.2019 13:00:00 CET | Pressemelding
PARIS and ASHBURN, Va., March 18, 2019 (GLOBE NEWSWIRE) -- Infovista, the leader in modern network performance, today announced new cloud-native management and control with next-generation Application Intelligence+ for Ipanema SD-WAN, delivering unmatched application performance across any WAN. Tweet This: Infovista enhances Ipanema SD-WAN with nextgen Application Intelligence+ and cloud native orchestration: https://bit.ly/2ULcKLW #SmarterSDWAN The enterprise network has become the central nervous system of modern digital businesses, and SD-WAN is enabling this digital transformation. Infovista’s Ipanema SD-WAN with new cloud-native management and control of applications tightly combines session-based routing and dynamic path selection of the underlay network with an overlay of deep application visibility and dynamic control of the quality of experience for business-critical applications. Additionally, Ipanema automatically understands application delivery requirements and maintains a
Inspirata and Ohio State University Continue to Break Digital Pathology Barriers18.3.2019 12:30:00 CET | Pressemelding
Columbus, Ohio Columbus, Ohio, March 18, 2019 (GLOBE NEWSWIRE) -- Less than one year ago Inspirata announced that their digital pathology solution was used to make the first-ever primary digital diagnosis in the U.S., initiating a new era in cancer diagnostics. Today, cancer informatics and digital pathology workflow solution provider Inspirata®, Inc. announced the company with the help of The Ohio State University Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute (OSUCCC-James) has broken another barrier- Inspirata and the OSUCCC – James have scanned over one-million anatomic pathology slides into high resolution whole slide digital images. “This historic accomplishment has demonstrated that it is possible to create large repositories of diagnostic quality prospective and retrospective slides creating imaging data that will accelerate clinical and research efforts,” says Inspirata Scan Center Manager, Trina Shanks, MLT (ACSP), CPC. Inspirata will presen